1. Beyond diabetes mellitus: role of metformin in non-muscle-invasive bladder cancer
   Z Wang et al, 2022, Singapore Medical Journal CrossRef
2. Metformin and bladder cancer: Drug repurposing as a potential tool for novel therapy: A review
   Yunzhu Feng et al, 2022, Medicine CrossRef
3. Formulation and characterization of 5-fluorouracil and metformin biodegradable nanospheres for treating colon cancer
   K. Bharathi Priya et al, 2024, Future Journal of Pharmaceutical Sciences CrossRef
4. Evaluation of Angiogenesis Process after Metformin and LY294002 Treatment in Mammary Tumor
   Marina G. Moschetta et al, 2019, Anti-Cancer Agents in Medicinal Chemistry CrossRef
5. Preclinical meritorious anticancer effects of Metformin against breast cancer: An In vivo trial
   Fatima Rizvi et al, 2021, Journal of Taibah University Medical Sciences CrossRef
6. Metformin: The next angiogenesis panacea?
   Yu Ren et al, 2021, SAGE Open Medicine CrossRef
7. Metformin sensitizes cholangiocarcinoma cell to cisplatin-induced cytotoxicity through oxidative stress mediated mitochondrial pathway
   Jaroon Wandee et al, 2019, Life Sciences CrossRef
8. Metformin attenuates cisplatin-induced genotoxicity and apoptosis in rat bone marrow cells
   Mohsen Cheki et al, 2021, Drug and Chemical Toxicology CrossRef
9. Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells
   Yanju Wu et al, 2019, Journal of Experimental & Clinical Cancer Research CrossRef
10. Study protocol of a phase II clinical trial of oral metformin for the intravesical treatment of non-muscle invasive bladder cancer
    Remco J. Molenaar et al, 2019, BMC Cancer CrossRef
11. Combined regimens of cisplatin and metformin in cancer therapy: A systematic review and meta-analysis
    Emad Jafarzadeh et al, 2022, Life Sciences CrossRef
12. Mechanisms of action of metformin and its regulatory effect on microRNAs related to angiogenesis
    Gang Wang et al, 2021, Pharmacological Research CrossRef
13. Metformin
    Meng H. Tan et al, 2016, Endocrinology and Metabolism Clinics of North America CrossRef
14. Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK-mTOR pathway
    Jaroon Wandee et al, 2018, Life Sciences CrossRef
15. AMPK: A promising molecular target for combating cisplatin toxicities
    Nadereh Rashtchizadeh et al, 2019, Biochemical Pharmacology CrossRef
16. The Use of Geroprotective Agents (mTOR Inhibitors) in the Treatment of Cancer Patients
    M. N. Yurova, 2020, Advances in Gerontology CrossRef
17. The Chemosensitizing Role of Metformin in Anti-Cancer Therapy
    Zhimin Tang et al, 2021, Anti-Cancer Agents in Medicinal Chemistry CrossRef